The Accelerating Access to Dementia and Alzheimer's Provider Training (AADAPT) Act aims to improve the diagnosis and care of Alzheimer's disease and related dementias, especially in underserved areas. It reauthorizes the Project ECHO Grant Program and introduces new grants for public or nonprofit entities to use technology-enabled collaborative learning models. These models provide virtual mentoring and training for primary care providers, enhancing their ability to diagnose and treat dementia. The bill defines eligible entities and health care professionals, sets application and reporting requirements, and mandates the Secretary of Health and Human Services to award these grants within one year and report on the program's progress within four years.
Supporters of the AADAPT Act highlight its potential to address the shortage of dementia specialists by equipping primary care providers with necessary skills through virtual training. This approach is expected to improve early diagnosis and quality care for Alzheimer's patients, particularly in rural and underserved communities. The bill's focus on technology-enabled learning is seen as a cost-effective method to expand healthcare access and provider retention.
Critics of the AADAPT Act express concerns about the reliance on virtual training, questioning its effectiveness compared to in-person education. There are also apprehensions regarding the implementation timeline, with some doubting whether the one-year deadline for awarding grants is feasible. Additionally, skeptics worry about the sustainability of funding and whether the authorized amounts will be appropriated, potentially limiting the program's impact.
The AADAPT Act, sponsored by Troy Balderson, presents significant potential conflicts of interest due to the substantial financial contributions from the health professionals sector, totaling $120 million. This sector directly overlaps with the bill's focus on health-related issues, raising concerns about whether the interests of these donors may unduly influence the legislative process. Given that Balderson's top donor industry is health professionals, it is crucial for voters to scrutinize how this financial backing may shape the bill's provisions and outcomes.
Additionally, while the lobbying activity related to this bill includes various undisclosed amounts from multiple organizations, the presence of significant lobbying efforts, such as the $100,000 from Dirshu International, further complicates the landscape. The lack of transparency regarding the specific lobbying amounts from other entities adds to the uncertainty surrounding potential conflicts. Voters should be aware that the financial ties between Balderson and the health sector could lead to legislation that favors donor interests over public welfare.
These industries are both affected by this bill and among the sponsor's top donors.
| Industry | Match Type | Related Subject | Donations |
|---|---|---|---|
| Health Professionals (H01) | Sector | Health | $120,000,000 |
| Total from overlapping industries | $120,000,000 | ||
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| DIRSHU INTERNATIONAL | MERKAVA STRATEGIES CORPORATION | $100,000 |
| CEO WORKS | SAUNDERS GLOBAL DIPLOMACY | $45,000 |
| KAZI IG | SAUNDERS GLOBAL DIPLOMACY | $15,000 |
| KEY LARGO WASTEWATER TREATMENT DISTRICT | HICKS-RICHARDSON ASSOCIATES | $10,000 |
| WATERFRONT GLOBAL | BBT STRATEGIES LLC | $5,200 |
| DIGITALEUROPE | VIVID STRATEGIES LLC | undisclosed |
| INTERNATIONAL CHRISTIAN CHAMBER OF COMMERCE | MERKAVA STRATEGIES CORPORATION | undisclosed |
| DR. STEPHEN SOLOWAY | MERKAVA STRATEGIES CORPORATION | undisclosed |
| ONE ISRAEL FUND | MERKAVA STRATEGIES CORPORATION | undisclosed |
| HEMOGLOBIN OXYGEN THERAPEUTICS | MERKAVA STRATEGIES CORPORATION | undisclosed |
| ATAOLLAH AMINPOUR | MERKAVA STRATEGIES CORPORATION | undisclosed |
| HERSEL NEMAN | MERKAVA STRATEGIES CORPORATION | undisclosed |
| MORAD BEN NEMAN | MERKAVA STRATEGIES CORPORATION | undisclosed |
| MARK SCOTT | MERKAVA STRATEGIES CORPORATION | undisclosed |
| BORIS MINTS | MERKAVA STRATEGIES CORPORATION | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Troy Balderson, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)